1. Home
  2. KMT vs NUVB Comparison

KMT vs NUVB Comparison

Compare KMT & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$29.66

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.85

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
NUVB
Founded
1938
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
KMT
NUVB
Price
$29.66
$5.85
Analyst Decision
Hold
Strong Buy
Analyst Count
6
8
Target Price
$36.00
$11.38
AVG Volume (30 Days)
1.3M
4.4M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
2.08%
N/A
EPS Growth
268.33
71.56
EPS
4.42
N/A
Revenue
$2,356,698,000.00
$62,902,000.00
Revenue This Year
$14.24
$203.82
Revenue Next Year
$7.57
$58.18
P/E Ratio
$6.75
N/A
Revenue Growth
19.82
698.96
52 Week Low
$20.35
$3.00
52 Week High
$43.81
$9.75

Technical Indicators

Market Signals
Indicator
KMT
NUVB
Relative Strength Index (RSI) 44.79 39.53
Support Level $28.40 $5.28
Resistance Level $31.15 $6.25
Average True Range (ATR) 0.84 0.28
MACD 0.16 -0.11
Stochastic Oscillator 40.66 15.67

Price Performance

Historical Comparison
KMT
NUVB

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: